Treatment of sleep apnea with prosthetic mandibular advancement (PMA).
Nine males with sleep apnea DOES syndrome and three males with sleep apnea DIMS syndrome were treated with prosthetic mandibular advancement (PMA). The method uses a prosthesis, which is designed to advance the mandible 3-5 mm to prevent upper airway occlusion during sleep. The apnea index in the obstructive-type apnea and the percentage of time spent in obstructive apnea decreased significantly with PMA. Although the apnea index showed merely a tendency to decrease in central apnea (p < 0.1), the percentage of time spent in central apnea decreased significantly with PMA. A marked improvement in sleep structures was observed with PMA; a significant increase was seen in total sleep time, percent slow wave sleep (SWS) and percent rapid eye movement (REM) sleep, and the time spent in intra-sleep awakening decreased remarkably. PMA had excellent effects on snoring, and daytime hypersomnolence was reduced in almost all patients. Moreover, a survey on the therapeutic effects of PMA on sleep apnea syndrome and problems associated with wearing PMA was performed with a questionnaire for the sample of nine DOES patients and an additional 22 patients who were treated over a long time. The therapeutic effects could be maintained without any problems in about 2/3 of these patients. The therapeutic mechanisms of PMA in its reduction of both obstructive and central apnea are discussed.
Nakazawa
Y
Y
Department of Neuropsychiatry, School of Medicine, Kurume University, Japan.
Sakamoto
T
T
Yasutake
R
R
Yamaga
K
K
Kotorii
T
T
Miyahara
Y
Y
Ariyoshi
Y
Y
Kameyama
T
T
D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008334:Mandible; D008875:Middle Aged; D009968:Orthodontic Appliances, Removable; D010342:Patient Acceptance of Health Care; D017286:Polysomnography; D012891:Sleep Apnea Syndromes / Q000628:therapy*; D012894:Sleep Stages; D012913:Snoring / Q000628:therapy; D014851:Wakefulness